Integrating inflammatory and nutritional markers: the prognostic value of the platelet-to-lymphocyte/albumin ratio for one-year all-cause mortality in patients undergoing transcatheter aortic valve implantation

Key Points

• One-year mortality is predicted by the platelet-to-lymphocyte ratio in TAVI patients.
• The study suggests a combination of inflammatory and nutritional markers enhances prognostic accuracy.
• Analysis of patient outcomes during TAVI reveals significant implications for pre-procedural planning.
• Adopting this integrated approach may lead to personalized risk assessment strategies for patients.